The critical care therapeutics market share is expected to increase by USD 888.68 million from 2020 to 2025, at a CAGR of 5%.

This critical care therapeutics market research report provides valuable insights on the post COVID-19 impact on the market, which will help companies evaluate their business approaches. Furthermore, this report extensively covers critical care therapeutics market segmentation by drug class (albumin, antithrombin, prothrombin complex, factor xIII, and fibrinogen) and geography (North America, Europe, Asia, and ROW). The critical care therapeutics market report also offers information on several market vendors, including Baxter International Inc., Bristol-Myers Squibb Co., CSL Ltd., Grifols SA, Kedrion Spa, LFB SA, Novartis AG, Octapharma AG, Pfizer Inc., and Takeda Pharmaceutical Co. Ltd. among others.

What will the Critical Care Therapeutics Market Size be During the Forecast Period?

Download the Free Report Sample to Unlock the Critical Care Therapeutics Market Size for the Forecast Period and Other Important Statistics

Critical Care Therapeutics Market: Key Drivers, Trends, and Challenges

Based on our research output, there has been a neutral impact on the market growth during and post COVID-19 era. The high demand for albumin in China is notably driving the critical care therapeutics market growth, although factors such as existence of plasma fractionation supply and demand gap may impede the market growth. Our research analysts have studied the historical data and deduced the key market drivers and the COVID-19 pandemic impact on the critical care therapeutics industry. The holistic analysis of the drivers will help in deducing end goals and refining marketing strategies to gain a competitive edge.

Key Critical Care Therapeutics Market Driver

The high demand for albumin in China will fuel the growth of the critical care therapeutics market size. China is the largest market for albumin products, followed by the US market. Albumin is being used as a volume replacement therapy apart from being used for kidney diseases, cirrhosis, and cancer. The demand for plasma products, especially albumin and immunoglobulins, is outstripping the supply. This is because of the stringent regulations imposed on the supply of raw materials and a ban on the import of plasma products. The vast difference in demand and supply is enabling the top players to enhance the prices of the products, and thus increase the revenues and contribute to the growth of the market. 

Key Critical Care Therapeutics Market Trend

The increasing surgical procedures will also contribute to the critical care therapeutics market growth. The increasing surgical procedures such as hip and knee replacements will increase the risk of DVT, driving the market growth. Surgeries often result in long periods of immobility, increasing the chances of developing DVT due to reduced blood flow. Individuals undergoing knee replacement and hip replacement surgeries have an increased likelihood of developing DVT. It is also observed that cases of joint replacements and cardiovascular procedures are more commonly observed among the elderly population. The increasing number of surgical procedures will drive the chances of developing thromboembolic events post surgeries, requiring treatment using anticoagulants. 

This critical care therapeutics market analysis report also provides detailed information on other upcoming trends and challenges that will have a far-reaching effect on the market growth. The actionable insights on the trends and challenges will help companies evaluate and develop growth strategies for 2021-2025.

Who are the Major Critical Care Therapeutics Market Vendors?

The report analyzes the market's competitive landscape and offers information on several market vendors, including:

• Baxter International Inc.
• Bristol-Myers Squibb Co.
• CSL Ltd.
• Grifols SA
• Kedrion Spa
• LFB SA
• Novartis AG
• Octapharma AG
• Pfizer Inc.
• Takeda Pharmaceutical Co. Ltd.

This statistical study of the critical care therapeutics market encompasses successful business strategies deployed by the key vendors. The critical care therapeutics market is fragmented and the vendors are deploying organic and inorganic growth strategies to compete in the market.

To make the most of the opportunities and recover from post COVID-19 impact, market vendors should focus more on the growth prospects in the fast-growing segments, while maintaining their positions in the slow-growing segments.

The critical care therapeutics market forecast report offers in-depth insights into key vendor profiles. The profiles include information on the production, sustainability, and prospects of the leading companies.

Which are the Key Regions for Critical Care Therapeutics Market?

For more insights on the market share of various regions Request for a FREE sample now!

39% of the market's growth will originate from North America during the forecast period. The US is a key market for critical care therapeutics in North America. However, market growth in this region will be slower than the growth of the market in Asia.

The growing investments in the US healthcare industry will facilitate the critical care therapeutics market growth in North America over the forecast period. This market research report entails detailed information on the competitive intelligence, marketing gaps, and regional opportunities in store for vendors, which will assist in creating efficient business plans.

What are the Revenue-generating Drug Class Segments in the Critical Care Therapeutics Market?

To gain further insights on the market contribution of various segments Request for a FREE sample

The critical care therapeutics market share growth by the albumin segment will be significant during the forecast period. The albumin segment of the market is expected to witness steady growth during the forecast period, owing to the high demand for albumin therapeutics in Asian countries such as China and India. Also, the increased exploitation of albumin in new therapeutic areas, along with the use for non-therapeutic purposes, is driving the critical care therapeutics market. The critical care therapeutics market share growth by the albumin segment will be faster than the prothrombin complex concentrates, antithrombin concentrates, factor XIII concentrates, and fibrinogen concentrates segments.    

This report provides an accurate prediction of the contribution of all the segments to the growth of the critical care therapeutics market size and actionable market insights on post COVID-19 impact on each segment.

Request for a FREE sample

What are the Key Data Covered in this Critical Care Therapeutics Market Report?

• CAGR of the market during the forecast period 2021-2025
• Detailed information on factors that will drive critical care therapeutics market growth during the next five years
• Precise estimation of the critical care therapeutics market size and its contribution to the parent market
• Accurate predictions on upcoming trends and changes in consumer behavior
• The growth of the critical care therapeutics industry across North America, Europe, Asia, and ROW
• A thorough analysis of the market's competitive landscape and detailed information on vendors
• Comprehensive details of factors that will challenge the growth of critical care therapeutics market vendors

We can help! Our analysts can customize this report to meet your requirements. Get in touch